Only 1 in 10 Gets Treatment: The Eating Disorder Access Crisis Insurance Built
- Only 10% of people with eating disorders receive treatment — the largest treatment gap of any mental health condition
- Residential ED treatment costs $1,000–$2,000 per day (30–90 day stays = $30,000–$180,000) — and less than 50% of the US population has adequate insurance coverage for it
- Insurance companies systematically delay, restrict, and deny eating disorder care: prior authorization barriers, shortened residential stays, and step-down denials are standard practice
- NIH grants for eating disorder research abruptly terminated in 2025 ($289,000 eliminated) — part of broader federal funding cuts affecting behavioral health research
Eating disorders have the highest mortality rate of any psychiatric illness. Anorexia nervosa's mortality rate is 5–10 times higher than the general population. And yet, 90% of people with eating disorders never receive treatment. This is not a clinical knowledge gap — we know how to treat eating disorders. It is a structural access failure, built into the insurance and funding systems that determine who gets care.
The insurance architecture of denial
The investigative reporting from Louisville Public Media documents the pattern: insurance companies require prior authorization that can take weeks. When residential treatment is finally approved, stays are systematically shortened — patients are discharged before clinical criteria are met because the insurer declares them "stable." Step-down to partial hospitalization is then denied, creating a gap between residential discharge and the next level of care that drives relapse.
The economic logic is straightforward: eating disorder treatment is expensive, and insurers minimize cost by minimizing approved days. But the clinical consequence is catastrophic: patients cycle through incomplete treatment episodes, each one increasing treatment resistance and mortality risk.
The research funding cut
The 2025 termination of NIH eating disorder research grants is a compounding blow. Eating disorders already receive disproportionately low research funding relative to their disease burden. The $289,000 in cancelled grants is modest in absolute terms but symbolic of a broader pattern: eating disorders are deprioritized at every level — insurance coverage, research funding, clinical training, and public awareness.
For your practice
For clinicians treating eating disorders: document medical necessity aggressively. Insurance denials are often reversed on appeal — but only when the clinical documentation is thorough. Learn your state's parity laws (mental health parity applies to eating disorders). For referral: the National Alliance for Eating Disorders (allianceforeatingdisorders.com) provides insurance navigation support. For advocacy: the data is now clear — 1 in 10 treated, $1,000–$2,000/day costs, systematic denial. Use these numbers when communicating with legislators, payers, and administrators.
Eating disorders have the highest mortality of any psychiatric illness. And 90% of people who have them never receive treatment. This is not a clinical failure — it is a system designed to deny care.
Treatment gap estimates vary by study and definition. Insurance coverage data is US-specific. The NIH grant termination may be partially reversed. Residential treatment costs vary significantly by facility and location.